- Home
- FRST vs AVIR Comparison
FRST vs AVIR Comparison
Compare FRST & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRST
- AVIR
- Stock Information
- Founded
- FRST 2004
- AVIR 2012
- Country
- FRST United States
- AVIR United States
- Employees
- FRST N/A
- AVIR N/A
- Industry
- FRST Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- FRST Finance
- AVIR Health Care
- Exchange
- FRST Nasdaq
- AVIR Nasdaq
- Market Cap
- FRST 290.5M
- AVIR 247.5M
- IPO Year
- FRST 2006
- AVIR 2020
- Fundamental
- Price
- FRST $11.71
- AVIR $3.26
- Analyst Decision
- FRST Buy
- AVIR Hold
- Analyst Count
- FRST 1
- AVIR 1
- Target Price
- FRST $14.00
- AVIR $6.88
- AVG Volume (30 Days)
- FRST 85.6K
- AVIR 503.8K
- Earning Date
- FRST 01-23-2025
- AVIR 11-07-2024
- Dividend Yield
- FRST 3.40%
- AVIR N/A
- EPS Growth
- FRST N/A
- AVIR N/A
- EPS
- FRST N/A
- AVIR N/A
- Revenue
- FRST $104,308,000.00
- AVIR N/A
- Revenue This Year
- FRST N/A
- AVIR N/A
- Revenue Next Year
- FRST $12.45
- AVIR N/A
- P/E Ratio
- FRST N/A
- AVIR N/A
- Revenue Growth
- FRST N/A
- AVIR N/A
- 52 Week Low
- FRST $9.52
- AVIR $2.75
- 52 Week High
- FRST $13.69
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- FRST 40.26
- AVIR 53.11
- Support Level
- FRST $11.62
- AVIR $3.10
- Resistance Level
- FRST $12.17
- AVIR $3.32
- Average True Range (ATR)
- FRST 0.29
- AVIR 0.14
- MACD
- FRST -0.09
- AVIR 0.03
- Stochastic Oscillator
- FRST 25.21
- AVIR 87.61
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).